Abstract
Ageing is a natural phenomenon which is a fold, ridge and crease in the skin that occurs
due to loss of body mass, poor hydration, disintegration of dermis and epidermis junction. The Skin
ageing process involves many changes that occur due to the combination of both endogenous factors
(gene mutation, cellular metabolism, and hormonal factor) and exogenous factors (U.V, pollutants,
chemical, and toxins). In 1950, the number of older people were found to be almost 205 million
across the globe. But this number almost got 4 times by the year 2012 and the number of older
persons increased to a massive amount of 810 million. The ageing of the skin occurs due to various
mechanisms like glycation, free radical, cell cycle, and cellular and molecular mechanism of skin
ageing. In this review article, we have discussed the treatment, worldwide newer therapies and
marketed formulation that are currently available for the reduction of skin ageing. The most promising
and revolutionizing field of nanotechnology is mostly applied in the field of dermatology,
cosmetics, and biomedical applications. Nanotechnology also plays a vital role in increasing the efficacy
of the product.
Keywords:
Treatment, nanotechnology, skin ageing, dermatology, nanocarriers, body mass.
Graphical Abstract
[1]
Miguel JD, Carlos HM, David MM. Ageing and the epidemiology of multimorbidity. Eur Respir J 2014; 44(4): 1055-68.
[13]
Phillips TJ, Demircay Z, Sahu M. Hormonal effects on skin aging. Europe PMC 2001; 17(4): 661-72.
[19]
Renault V, Throne LE, Eriksson PO. Gillian butler- Browne. Vincemt Mouly 2002; 1(4): 188.
[23]
Harman D. Free radical theory of aging mutation. Mutat Res Rev Mutat Res 2003; 5: 5.
[25]
Andrew PW. Ageing and the free radical theory. Respir Physiol 2001; 128(3): 379-91.
[26]
Golias CH, Charalabopoulos A, Charalabopoulos K. Cell proliferation and cell cycle control: a mini review. Int J Clin Pract 2004; 58(12): 1134-41.
[27]
El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25.
[39]
Freymiller EG. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004; 62(4): 1046-7.
[44]
Coffield JA, Considine RB, Simpson LL. The site and mechanism of action of botulinum neurotoxin Therapy with botulinum toxin. New York: Dekker 1994; pp. 3-14.
[46]
Yadav NK, Nanda S, Sharma G, Katare OP. Systematically optimized coenzyme q10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation. J Drug Target 2016; 24(3): 257-71.